Levatinib Intermediate
have 0 Relevant products
Levatinib Is An Oral, Multi-Target Tyrosine Kinase Inhibitor That Inhibits The Ic50 Of Vegfr2 (Kdr) And Vegfr3 (Flt-4) At 4 And 5.2 Nm, Respectively. Levatinib Is An Anticancer Drug Used To Treat Some Types Of Thyroid Cancer And Other Cancers.
